All News

Link suspected between diabetes drug, pancreatitis.

Apria Healthcare Group to acquire Coram.

FDA expands label for bortezomib (Velcade) for patients with impaired kidney function.

Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.

Topotecan granted FDA approval for relapsed small cell lung cancer.

Rite Aid and Lindora to expand California in-store clinics.

NABP awards DMEPOS accreditation to Walgreen Co.

Makers of homeopathic products push their cough and cold remedies in the wake of the withdrawal OTC cough and cold products for infants.

A new report requested by Rep. Henry Waxman finds that private insurers are not operating their Medicare Part D programs efficiently.

Although the number of independent pharmacies has decreased from 2006, salary levels for pharmacists and technicians have increased.

WellPoint opens specialty pharmacy in airport

Dietary supplements confiscated by FDA

John Rector plans to step down from his position as general counsel for NCPA in 2008

FDA issues new warnings about Definity and Optison contrast agents

States look to expand Medicaid benefits and eligibility as the program enrollment and spending remain low.

Consumers Union, publisher of Consumer Reports, criticizes the Centers for Medicare & Medicaid Service's system for rating Medicare Part D prescription drug plans as meaningless.

Outcomes Pharmaceutical Health Care has released a new version of its medication therapy management (MTM) systems.

The eye care community is disconcerted by Genentech's decision to restrict access to its cancer drug Avastin.

OIG report finds the Centers for Medicare & Medicaid Services was slow to respond to fraud allegations against prescription drug plans and lacked an antifraud strategy.

Three deaths determined to be result of colchicine toxicity

Maryland pharmacists urge House Majority Leader Hoyer to put patients first

Children are using more medications to treat gastrointestinal problems

The National Association of Boards of Pharmacy has reinstated the North American Pharmacist Licensure Exam at all the Prometric testing centers.

The Centers for Medicare & Medicaid Services has released an improved plan finder with details on 2008 Medicare Part D prescription drug plans.

Two Hispanic pharmacy chains combine under Navarro name

Several manufacturers withdraw over-the-counter cough and cold products

New metabolic warnings added to olanzapine product labels

First oxcarbazepine receives approval for seizure disorders